The Herbert and Jacqueline Krieger Klein Alzheimer’s Research Center at the Brain Health Institute (BHI), is seeing a faculty level expert in fluid biomarkers for a tenure-track position at the Associate or Full Professor level at BHI, and Robert Wood Johnson Medical School (RWJMS) within Rutgers Health. We seek a faculty member who is experienced in the identification, validation, and utilization of fluid biomarkers in the diagnosis, prognosis, and treatment of Alzheimer’s disease (AD) and AD related disorders (ADRD). The successful candidate will work as part of a multi-disciplinary team including neurologists, neuropsychologists, neuroimaging experts and neuropathologists. The AD center will develop a research cohort of individuals at high risk for dementia. This cohort will be extensively phenotyped for clinical, cognitive, genetic, neuroimaging, behavioral, digital and blood biomarker measures. In addition to scientific leadership, responsibilities will also include mentorship of young investigators. Applicants must have experience in conducting large-scale longitudinal fluid biomarker studies, and an interest in studying the earliest stages of AD. The successful candidate will be responsible for leading and conducting cutting-edge research in fluid biomarkers associated with ADRD.
Qualifying tenure-track applicants must have an established scholarly record demonstrating ability to develop and lead a program of independent, NIH (or other extramurally) funded research. Successful applicant(s) will serve as a core member(s) within the Herbert and Jacqueline Krieger Klein Alzheimer’s Center at BHI, with a primary appointment in one of the relevant departments at RWJMS, including Psychiatry, Neurology and Neurosurgery. The Herbert and Jacqueline Krieger Klein Alzheimer’s Center is a new center within BHI at Rutgers University with the mission of establishing an interdisciplinary, integrated program to provide comprehensive research focused on prevention and treatment of ADRD. This center is the first of its kind in New Jersey, and the successful applicant will be integral to its development. Ideal candidates will bring vision and experience in modern aging and memory research and enthusiasm for team science and collaboration.
Minimum Education and Experience
Ph.D. and/or M.D. with relevant specialization in Alzheimer’s disease, neurology, psychiatry, biochemistry, or a related field.
A research program with currently active federal funding. Preference will be given to investigators at the Associate Professor level or above. However, superb young investigators with NIH funding and a high potential for scientific independence and success will also be considered. Physician-scientists are highly encouraged to apply, but clinical credentials are not a requirement for the position.
— Research experience in fluid biomarkers associated with ADRD, especially with identifying novel biomarkers, developing assays, and validating the utility of biomarkers for diagnosis and monitoring disease.
— Experience applying statistical and data analysis techniques to interpret biomarker data.
— Ability to develop and lead a program of independent, extramurally funded research including a record of leadership of, or contributions to, major successful peer-reviewed grant proposals appropriate to the applicant’s academic rank.
— Academic credentials that qualify for appointment at the Associate Professor level or above, at Rutgers University including a record of successful extramural funding and peer-reviewed publications addressing Alzheimer’s disease and Alzheimer’s disease related disorders. Superb young investigators with NIH funding and a high potential for scientific independence and success will be considered.
— Record of successful multi-disciplinary collaboration and mentorship of students and early-stage investigators.
— Excellent written and oral communication skills and the ability to communicate research findings and concepts to both academic and non-academic audiences.
— Ability to successfully engage and communicate with study participants, community, and public policy leaders.
— Strong interest and enthusiasm in helping achieve successful implementation of the new cohort and contributing to cutting-edge science.